T. Rowe Price Associates’s Evoqua Water Technologies Corp. Common Stock AQUA Stock Holding History

T. Rowe Price Associates’s Portfolio AQUA Stock Details AQUA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-589,981	Closed	-$29.3M	–	3013
2023 Q1	$29.3M	Sell	589,981 -23,206	-4%	-$1.08M	﹤0.01%	822
2022 Q4	$24.3M	Buy	613,187 +2,841	+0.5%	+$112K	﹤0.01%	859
2022 Q3	$20.2M	Buy	610,346 +61,517	+11%	+$2.23M	﹤0.01%	900
2022 Q2	$17.8M	Buy	548,829 +340,029	+163%	+$12.9M	﹤0.01%	1201
2022 Q1	$9.81M	Buy	208,800 +176,138	+539%	+$7.52M	﹤0.01%	1370
2021 Q4	$1.53M	Sell	32,662 -1,928	-6%	-$83.9K	﹤0.01%	1816
2021 Q3	$1.3M	Sell	34,590 -2,259	-6%	-$81.6K	﹤0.01%	1914
2021 Q2	$1.25M	Buy	36,849 +3,082	+9%	+$92.7K	﹤0.01%	1971
2021 Q1	$888K	Buy	33,767 +17,205	+104%	+$458K	﹤0.01%	2112
2020 Q4	$447K	Buy	+16,562	New	+$411K	﹤0.01%	2291

Other funds holding AQUA

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

T. Rowe Price Associates's AQUA Position: Q2 2023 in Review

T. Rowe Price Associates sold out of Evoqua Water Technologies Corp. Common Stock (AQUA) in Q2 2023, closing a stake of 589,981 shares — an estimated $29.3M sold.

T. Rowe Price Associates first reported a position in AQUA in Q4 2020 and held it in 10 quarters. The position peaked at $29.3M in Q1 2023. 1 fund tracked by Wall St. Rank holds AQUA as of Q2 2023.

T. Rowe Price Associates reported no remaining Evoqua Water Technologies Corp. Common Stock position as of Q2 2023 after selling out during the quarter.
T. Rowe Price Associates sold 589,981 Evoqua Water Technologies Corp. Common Stock shares in Q2 2023, an estimated $29.3M.
T. Rowe Price Associates first reported a position in Evoqua Water Technologies Corp. Common Stock in Q4 2020 and held it in 10 quarters.
T. Rowe Price Associates's Evoqua Water Technologies Corp. Common Stock position peaked at $29.3M in Q1 2023.
1 fund tracked by Wall St. Rank held Evoqua Water Technologies Corp. Common Stock as of Q2 2023.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.